Subscribe to RSS
Transient Hypoglycemia and Biochemical Differences in Infants Less Than 1,250 G at Birth Fed Human Milk with Human Milk–Derived Fortifier versus Cow Milk–Derived FortifierFunding None
Objective Fortification of human milk (HM) with either human milk-derived fortifier (HMDF) or cow milk-derived fortifier (CMDF) is important in preterm infants. The objective is to compare the incidence of hypoglycemia, and biochemical values in infants less than 1,250 g at birth fed HMDF versus CMDF.
Study Design It is a retrospective cohort study on infants less than 1,250 g at birth who were fed with HMDF or CMDF. Hypoglycemia was defined as blood glucose (BG) level equal to or less than 60 mg/dL within 72 hours of full enteral feeds when off total parenteral nutrition and intravenous fluids.
Results Ninety infants were enrolled (HMDF = 61, CMDF = 29). HMDF group had a higher rate of hypoglycemia (46 vs. 24%; p = 0.048) after achievement of full enteral feeding. The median minimum BG was lower (61 vs. 71; p ≤ 0.01), while blood urea nitrogen (12 vs. 6; p ≤ 0.01) and albumin (3.1 vs. 2.7; p ≤ 0.01) were higher in HMDF group compared with CMDF.
Conclusion At full enteral feedings in infants less than 1,250 g at birth, an HMDF diet may predispose to hypoglycemia needing intervention. Close monitoring of BG levels once off parenteral nutrition is recommended.
Exclusive human milk (EHM) feeding results in better nutritional indices.
EHM feeding at higher calorie/ounce improves growth.
Blood glucose needs to be monitored when off TPN during EHM feeding.
M.R.C. was responsible for creating the database, data collection and analysis, results interpretation, and writing the manuscript. M.T. contributed to database creation, data analysis, results interpretation, and writing the manuscript. L.B. contributed to gathering the demographic data from the database and writing the manuscript. R.R. contributed to study design, results interpretation, and revising the manuscript. R.C. contributed to study design, data analysis, results interpretation, and writing the manuscript.
Received: 12 April 2023
Accepted: 30 August 2023
Accepted Manuscript online:
01 September 2023
Article published online:
25 September 2023
© 2023. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
- 1 Eidelman AI. Breastfeeding and the use of human milk: an analysis of the American Academy of Pediatrics 2012 Breastfeeding Policy Statement. Breastfeed Med 2012; 7 (05) 323-324
- 2 Schanler RJ, Shulman RJ, Lau C. Feeding strategies for premature infants: beneficial outcomes of feeding fortified human milk versus preterm formula. Pediatrics 1999; 103 (6 Pt 1): 1150-1157
- 3 Assad M, Elliott MJ, Abraham JH. Decreased cost and improved feeding tolerance in VLBW infants fed an exclusive human milk diet. J Perinatol 2016; 36 (03) 216-220
- 4 Chen AC, Chung MY, Chang JH, Lin HC. Pathogenesis implication for necrotizing enterocolitis prevention in preterm very-low-birth-weight infants. J Pediatr Gastroenterol Nutr 2014; 58 (01) 7-11
- 5 Gordon PV, Swanson JR. Necrotizing enterocolitis is one disease with many origins and potential means of prevention. Pathophysiology 2014; 21 (01) 13-19
- 6 Abrams SA, Schanler RJ, Lee ML, Rechtman DJ. Greater mortality and morbidity in extremely preterm infants fed a diet containing cow milk protein products. Breastfeed Med 2014; 9 (06) 281-285
- 7 Sullivan S, Schanler RJ, Kim JH. et al. An exclusively human milk-based diet is associated with a lower rate of necrotizing enterocolitis than a diet of human milk and bovine milk-based products. J Pediatr 2010; 156 (04) 562-567.e1
- 8 Hair AB, Peluso AM, Hawthorne KM. et al. Beyond necrotizing enterocolitis prevention: improving outcomes with an exclusive human milk-based diet. Breastfeed Med 2016; 11 (02) 70-74
- 9 Heller CD, O'Shea M, Yao Q. et al; NICHD Neonatal Research Network. Human milk intake and retinopathy of prematurity in extremely low birth weight infants. Pediatrics 2007; 120 (01) 1-9
- 10 Patel AL, Johnson TJ, Engstrom JL. et al. Impact of early human milk on sepsis and health-care costs in very low birth weight infants. J Perinatol 2013; 33 (07) 514-519
- 11 Corpeleijn WE, Kouwenhoven SM, Paap MC. et al. Intake of own mother's milk during the first days of life is associated with decreased morbidity and mortality in very low birth weight infants during the first 60 days of life. Neonatology 2012; 102 (04) 276-281
- 12 Schanler RJ, Lau C, Hurst NM, Smith EO. Randomized trial of donor human milk versus preterm formula as substitutes for mothers' own milk in the feeding of extremely premature infants. Pediatrics 2005; 116 (02) 400-406
- 13 Narayanan I, Prakash K, Murthy NS, Gujral VV. Randomised controlled trial of effect of raw and holder pasteurised human milk and of formula supplements on incidence of neonatal infection. Lancet 1984; 2 (8412): 1111-1113
- 14 O'Connor DL, Ewaschuk JB, Unger S. Human milk pasteurization: benefits and risks. Curr Opin Clin Nutr Metab Care 2015; 18 (03) 269-275
- 15 O'Connor DL, Gibbins S, Kiss A. et al; GTA DoMINO Feeding Group. Effect of supplemental donor human milk compared with preterm formula on neurodevelopment of very low-birth-weight infants at 18 months: a randomized clinical trial. JAMA 2016; 316 (18) 1897-1905
- 16 Sisk PM, Lambeth TM, Rojas MA. et al. Necrotizing enterocolitis and growth in preterm infants fed predominantly maternal milk, pasteurized donor milk, or preterm formula: a retrospective study. Am J Perinatol 2017; 34 (07) 676-683
- 17 Ong ML, Belfort MB. Preterm infant nutrition and growth with a human milk diet. Semin Perinatol 2021; 45 (02) 151383
- 18 Ehrenkranz RA, Das A, Wrage LA. et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Early nutrition mediates the influence of severity of illness on extremely LBW infants. Pediatr Res 2011; 69 (06) 522-529
- 19 Soldateli B, Parker M, Melvin P, Gupta M, Belfort M. Human milk feeding and physical growth in very low-birth-weight infants: a multicenter study. J Perinatol 2020; 40 (08) 1246-1252
- 20 Montjaux-Régis N, Cristini C, Arnaud C, Glorieux I, Vanpee M, Casper C. Improved growth of preterm infants receiving mother's own raw milk compared with pasteurized donor milk. Acta Paediatr 2011; 100 (12) 1548-1554
- 21 Lloyd ML, Malacova E, Hartmann B, Simmer K. A clinical audit of the growth of preterm infants fed predominantly pasteurised donor human milk v. those fed mother's own milk in the neonatal intensive care unit. Br J Nutr 2019; 121 (09) 1018-1025
- 22 McNelis K, Liu C, Ehrlich S, Fields C, Fields T, Poindexter B. Body composition of very low-birth-weight infants fed fortified human milk: a pilot study. J Parent Enteral Nutr 2021; 45 (04) 784-791
- 23 Thornton PS, Stanley CA, De Leon DD. et al; Pediatric Endocrine Society. Recommendations from the Pediatric Endocrine Society for Evaluation and Management of Persistent Hypoglycemia in Neonates, Infants, and Children. J Pediatr 2015; 167 (02) 238-245
- 24 Ho HT, Yeung WK, Young BW. Evaluation of “point of care” devices in the measurement of low blood glucose in neonatal practice. Arch Dis Child Fetal Neonatal Ed 2004; 89 (04) F356-F359
- 25 Bell MJ, Ternberg JL, Feigin RD. et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg 1978; 187 (01) 1-7
- 26 Ackley D, Wang H, D'Angio CT, Meyers J, Young BE. Human milk-derived fortifiers are linked with feed extension due to hypoglycemia in infants <1250 g or <30 weeks: a matched retrospective chart review. J Perinatol 2023; 43 (05) 624-628
- 27 Yuan ZX, Gao H, Duan CC, Wang Y, Wang LL. [Risk factors for hypoglycemia in preterm infants with a gestational age of ≤32 weeks]. Zhongguo Dang Dai Er Ke Za Zhi 2020; 22 (11) 1154-1158
- 28 Sharma A, Davis A, Shekhawat PS. Hypoglycemia in the preterm neonate: etiopathogenesis, diagnosis, management and long-term outcomes. Transl Pediatr 2017; 6 (04) 335-348
- 29 Brion LP, Rosenfeld CR, Heyne R. et al. Optimizing individual nutrition in preterm very low birth weight infants: double-blinded randomized controlled trial. J Perinatol 2020; 40 (04) 655-665
- 30 Gianni ML, Roggero P, Mosca F. Human milk protein vs. formula protein and their use in preterm infants. Curr Opin Clin Nutr Metab Care 2019; 22 (01) 76-81
- 31 Chetta KE, Hair AB, Hawthorne KM, Abrams SA. Serum phosphorus levels in premature infants receiving a donor human milk derived fortifier. Nutrients 2015; 7 (04) 2562-2573
- 32 Quigley M, Embleton ND, McGuire W. Formula versus donor breast milk for feeding preterm or low birth weight infants. Cochrane Database Syst Rev 2018; 6 (06) CD002971
- 33 Lucas A, Boscardin J, Abrams SA. Preterm infants fed cow's milk-derived fortifier had adverse outcomes despite a base diet of only mother's own milk. Breastfeed Med 2020; 15 (05) 297-303
- 34 Dusick AM, Poindexter BB, Ehrenkranz RA, Lemons JA. Growth failure in the preterm infant: can we catch up?. Semin Perinatol 2003; 27 (04) 302-310
- 35 Ehrenkranz RA, Younes N, Lemons JA. et al. Longitudinal growth of hospitalized very low birth weight infants. Pediatrics 1999; 104 (2 Pt 1): 280-289
- 36 Clark RH, Thomas P, Peabody J. Extrauterine growth restriction remains a serious problem in prematurely born neonates. Pediatrics 2003; 111 (5 Pt 1): 986-990
- 37 Shen W, Zheng Z, Lin XZ. et al; Nutritional Committee of Neonatology Branch of ChineseMedical Doctor Association, National Multicenter EUGR Collaborative Group. Incidence of extrauterine growth retardation and its risk factors in very preterm infants during hospitalization: a multicenter prospective study. Zhongguo Dang Dai Er Ke Za Zhi 2022; 24 (02) 132-140
- 38 Hair AB, Hawthorne KM, Chetta KE, Abrams SA. Human milk feeding supports adequate growth in infants ≤ 1250 grams birth weight. BMC Res Notes 2013; 6: 459
- 39 Huston RK, Markell AM, McCulley EA, Gardiner SK, Sweeney SL. Improving growth for infants ≤1250 grams receiving an exclusive human milk diet. Nutr Clin Pract 2018; 33 (05) 671-678